COVID-19: Information for Healthcare Professionals & the Respiratory Community
CTS Guidance Documents
Our CTS members and experts from across the country are developing position statements to help Canadian physicians optimize management for their patients during the COVID-19 pandemic. The position statements are published in the CTS Canadian Journal of Respiratory Critical Care and Sleep Medicine. They are also available in the CTS Guideline Library.
The pandemic is a rapidly evolving situation and this page will be updated frequently as information becomes available. If you have suggestions for how CTS can best support the respiratory, critical care, and sleep medicine community, please contact: Anne Van Dam at email@example.com.
CTS Statement on Salbutamol Inhaler Shortage
The CTS participated in multi-stakeholder meetings with Health Canada to discuss mitigation strategies for an emerging salbutamol inhaler shortage in Canada during the COVID-19 pandemic. The CTS Asthma and COPD Assembly Steering Committees developed rapid guidance for Canadian physicians recommending options for Salbutamol MDI substitutions in the event of a shortage.
Join your Newfoundland & Labrador Colleagues in asking Canadians for their help to self-isolate! Send us your video or tweet about it!